Form 4: Arteris COO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, sold 32,775 shares of common stock for approximately $15.42 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Laurent R. Moll, Chief Operating Officer of Arteris, Inc. (AIP), reported a sale of common stock.
- The transaction involved the disposition of 32,775 shares of Arteris, Inc. common stock.
- The shares were sold at a weighted average price of $15.4233 per share.
- Individual sale prices ranged from $14.90 to $15.90.
- The sale was executed on November 5, 2025.
- This transaction was conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Moll on March 12, 2025.
- Following the transaction, Mr. Moll beneficially owns 311,110 shares of common stock directly.
Sentiment
Score: 5
Explanation: The filing reports an insider sale of common stock by the Chief Operating Officer. While insider selling can be perceived negatively, the transaction was executed under a pre-arranged Rule 10b5-1 trading plan, which suggests it is part of a long-term personal financial strategy rather than a reaction to recent company performance or outlook. The transaction date is in the future, indicating it was scheduled well in advance.
Negatives
- Chief Operating Officer Laurent R. Moll sold 32,775 shares of common stock.
- Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as it reduces management's direct equity stake.
Future Outlook
No future outlook or guidance is provided in this Form 4 filing, as it is solely a report of an insider transaction.
Industry Context
This filing is specific to an insider transaction at Arteris, Inc. and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders may view the insider sale as a slight negative, though this is mitigated by the fact that it was executed under a pre-arranged 10b5-1 plan, indicating a planned financial event rather than a reaction to new information.
Next Steps
- The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.
Key Dates
| Date | Description |
|---|---|
| 2025-03-12 | Date the 10b5-1 trading plan was adopted by Laurent R. Moll. |
| 2025-11-05 | Date of the reported transaction (sale of common stock). |
| 2025-11-07 | Date the Form 4 was signed by the attorney-in-fact for Laurent R. Moll. |
Recommendation
holdThe reported insider sale by the Chief Operating Officer is a routine transaction executed under a pre-arranged 10b5-1 trading plan. Such sales are often for personal financial planning and do not necessarily reflect a change in the company's fundamental outlook or the officer's confidence. Therefore, this specific filing alone does not provide sufficient new information to alter an existing investment thesis, warranting a 'hold' recommendation.
Keywords
Arteris Inc., AIP, Form 4, Insider Trading, Stock Sale, Laurent R. Moll, Chief Operating Officer, 10b5-1 Plan, Equity Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.